Home  »  Stock   »  Teva Pharmaceutical Industries Limited (TEVA) mark...

Teva Pharmaceutical Industries Limited (TEVA) market price of $8.83 offers the impression of an exciting value play

Let’s start up with the current stock price of Teva Pharmaceutical Industries Limited (TEVA), which is $8.83 to be very precise. The Stock rose vividly during the last session to $8.85 after opening rate of $8.64 while the lowest price it went was recorded $8.515 before closing at $8.72.Recently in News on November 21, 2022, Teva Announces Appointment of Richard Francis as President and CEO. Kåre Schultz to Retire After a Transformative Five-Year Tenure Setting the Stage for an Exciting Future. You can read further details here

Teva Pharmaceutical Industries Limited had a pretty Dodgy run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $11.34 on 08/11/22, with the lowest value was $6.78 for the same time period, recorded on 07/14/22.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free.


Teva Pharmaceutical Industries Limited (TEVA) full year performance was -0.56%

Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, Teva Pharmaceutical Industries Limited shares are logging -22.13% during the 52-week period from high price, and 30.25% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $6.78 and $11.34.

The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 7015533 for the day, which was evidently lower, when compared to the average daily volumes of the shares.

When it comes to the year-to-date metrics, the Teva Pharmaceutical Industries Limited (TEVA) recorded performance in the market was 10.24%, having the revenues showcasing -12.23% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 9.92B, as it employees total of 34713 workers.

Market experts do have their say about Teva Pharmaceutical Industries Limited (TEVA)

During the last month, 2 analysts gave the Teva Pharmaceutical Industries Limited a BUY rating, 1 of the polled analysts branded the stock as an OVERWEIGHT, 10 analysts were recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 1 of the polled analysts provided SELL rating.

According to the data provided on Barchart.com, the moving average of the company in the 100-day period was set at 8.77, with a change in the price was noted +1.31. In a similar fashion, Teva Pharmaceutical Industries Limited posted a movement of +17.42% for the period of last 100 days, recording 11,935,205 in trading volumes.

Total Debt to Equity Ratio (D/E) can also provide valuable insight into the company’s financial health and market status. The debt to equity ratio can be calculated by dividing the present total liabilities of a company by shareholders’ equity. Debt to Equity thus makes a valuable metrics that describes the debt, company is using in order to support assets, correlating with the value of shareholders’ equity The total Debt to Equity ratio for TEVA is recording 2.43 at the time of this writing. In addition, long term Debt to Equity ratio is set at 2.11.

Technical breakdown of Teva Pharmaceutical Industries Limited (TEVA)

Raw Stochastic average of Teva Pharmaceutical Industries Limited in the period of last 50 days is set at 59.50%. The result represents improvement in oppose to Raw Stochastic average for the period of the last 20 days, recording 52.07%. In the last 20 days, the company’s Stochastic %K was 46.15% and its Stochastic %D was recorded 50.10%.

Bearing in mind the latest performance of Teva Pharmaceutical Industries Limited, several moving trends are noted. Year-to-date Price performance of the company’s stock appears to be pessimistic, given the fact the metric is recording 10.24%. Additionally, trading for the stock in the period of the last six months notably improved by 4.50%, alongside a downfall of -0.56% for the period of the last 12 months. The shares increased approximately by -5.46% in the 7-day charts and went down by 4.62% in the period of the last 30 days. Common stock shares were lifted by -12.23% during last recorded quarter.

Leave a Comment

Your email address will not be published. Required fields are marked *

On Key

Related Posts